Indolinones compounds and their use in the treatment of fibrotic diseases
US11046672B2 · kind B2 · utility
0Cited by
1References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 23, 2016 |
| Grant date | Jun 29, 2021 |
| Priority date | — |
| Expiry date | Feb 21, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates inter alia to a compound of formula (I) Wherein R1, R2, R3 and Z are as defined in the specification and to compositions comprising the same and to the use of the compounds and to compositions of the compounds in treatment, for example in the treatment of fibrotic diseases or interstitial lung diseases, in particular idiopathic pulmonary fibrosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.